FDA Inspection 1209356 — Melissa L. Johnson, M.D.
The FDA completed an inspection of Melissa L. Johnson, M.D. on Jun 16, 2023 in Nashville, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional details
Clinical Investigator (CI)